SUBSEQUENT EVENTS (Details)			2 Months Ended	3 Months Ended	6 Months Ended
	Aug. 15, 2022 USD ($)	Aug. 01, 2022 USD ($) item $ / shares shares	Aug. 31, 2022 USD ($) shares	Jun. 30, 2022 USD ($)	Jun. 30, 2022 USD ($)	Jun. 30, 2021 USD ($)
Subsequent Event [Line Items]
Issuance of common stock under the Sales Agreement, net				$ 2,641,000	$ 2,641,000	$ 8,575,000
Subsequent Event
Subsequent Event [Line Items]
Issuance of common stock under the Sales Agreement, net			$ 1,152,650
Issuance of common stock under the Sales Agreement, net (in shares) | shares			1,040,457
Subsequent Event | Option to purchase shares of common stock | Employee | 2006 Employee Stock Incentive Plan
Subsequent Event [Line Items]
Term of award		10 years
Granted (in shares) | shares		160,000
Exercise Price (in dollars per share) | $ / shares		$ 1.06
Vesting Period		4 years
Number of equal quarterly increments | item		16
Grant Date Fair Value		$ 124,000
Share price | $ / shares		$ 1.06
Dividend Yield		0.00%
Expected Volatility Rate		85.95%
Risk Free Interest Rate		2.65%
Expected Term		6 years
Subsequent Event | Pfizer Agreement [Member]
Subsequent Event [Line Items]
Proceeds From Sale Of Products	$ 1,100,000
Subsequent Event | Chiesi Agreements | Alfataliglicerase
Subsequent Event [Line Items]
Proceeds from expense reimbursements	$ 1,100,000